Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Imrex is a Canadian animal health company focused on veterinary oral health products for companion animals. The company markets commercial products intended to improve dental hygiene, reduce plaque and tartar burden, and address bad breath in dogs and cats, rather than developing a traditional human biopharma therapeutic pipeline. Its product portfolio appears centered on patent-pending oral care formulations and related veterinary dental care solutions sold through animal health channels. Imrex positions itself as an innovation- and formulation-driven manufacturer serving veterinarians, pet owners, and distribution partners globally. Based on the available evidence, it is best characterized as a commercial-stage pet healthcare products company rather than a clinical-stage biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Imrex.